Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718829 | SCV000513079 | likely benign | not provided | 2021-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314144 | SCV000849142 | likely benign | Inborn genetic diseases | 2017-02-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000862904 | SCV001003470 | likely benign | Rett syndrome, congenital variant | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001718829 | SCV004129157 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | FOXG1: BP4, BP7 |
Prevention |
RCV003972574 | SCV004787085 | likely benign | FOXG1-related disorder | 2019-02-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |